Form 4: Tenon Medical CEO Converts RSUs to Common Stock

Steven M. Foster, CEO and President of Tenon Medical, Inc., converted 140,936 restricted stock units into common stock, increasing his direct ownership.

Summary

• Steven M. Foster, the CEO and President of Tenon Medical, Inc. (TNON), converted 140,936 restricted stock units (RSUs) into an equal number of common stock shares.
• The conversion transaction occurred on January 1, 2026.
• Following this conversion, Mr. Foster directly beneficially owns 163,814 shares of Tenon Medical, Inc. common stock.
• The RSUs were originally granted to Mr. Foster on October 13, 2025.

Sentiment

Score: 7

Explanation: The conversion of restricted stock units into common stock by a CEO is generally viewed positively as it increases direct ownership and aligns management's interests with shareholders, signaling confidence in the company's long-term value.

Positives

• The conversion of restricted stock units into common stock increases the CEO's direct ownership in the company, aligning his interests more closely with those of public shareholders.
• This transaction demonstrates management's continued confidence in the company's future prospects.

Stakeholder Impact

• Shareholders: Increased alignment of management's interests with shareholders due to higher direct stock ownership.

Key Dates

Recommendation

The conversion of restricted stock units into common stock by the CEO is a positive signal, indicating management's confidence and increased alignment with shareholder interests. However, a Form 4 filing alone does not provide sufficient comprehensive financial or operational data to warrant a 'buy' or 'sell' recommendation. It serves as a supportive data point for a 'hold' position, suggesting no immediate negative catalysts from this specific event.

Keywords

Tenon Medical, TNON, Steven M. Foster, CEO, Restricted Stock Units, RSU conversion, Common Stock, Insider Transaction, Beneficial Ownership